First Selective 12-LOX Inhibitor, ML355, Impairs Thrombus Formation and Vessel Occlusion In Vivo With Minimal Effects on HemostasisReheman Adili, Michael Holinstat, John C. Freedman et al.|Arteriosclerosis Thrombosis and Vascular Biology|2017Cited by 112
Platelet 12-LOX is essential for FcγRIIa-mediated platelet activationJennifer Yeung, Michael Holinstat, Benjamin E. Tourdot et al.|Blood|2014Cited by 93